Cognition, social cognition and functioning in schizophrenia;Cognição, cognição social e funcionalidade na esquizofrenia

Acta Medica Portuguesa

Volumn 23, Issue 6, 2010, Pages 1043-1058

  Vaz Serra, Adriano ^a   Palha, António ^a   Figueira, Maria Luísa ^a   Bessapeixoto, Alberto ^a   Brissos, Sofia ^a   Casquinha, Paula ^a   Damas Reis, Filipe ^a   Ferreira, Luís ^a   Gago, Joaquim ^a   Jara, José ^a   Relvas, João ^a   Marques Teixeira, João ^a  

^a Grupo de Trabalho em Esquizofrenia   (Venezuela)

Author keywords

[No Author keywords available]

Indexed keywords

ALERTNESS; ARTICLE; ATTENTION; COGNITION; COGNITIVE DEFECT; EXECUTIVE FUNCTION; HUMAN; INTELLIGENCE QUOTIENT; LANGUAGE; MEMORY; NEUROPSYCHOLOGICAL TEST; SCHIZOPHRENIA; SOCIAL COGNITION; VERBAL MEMORY;

COGNITION; HUMANS; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; SOCIAL BEHAVIOR;

EID: 78751512664     PISSN: None     EISSN: 16460758     Source Type: Journal    
DOI: None     Document Type: Article

References (105)

1. KOPELOWICZ A, LIBERMAN RP, VENTURA J, ZARATE R, MINTZ J: Neurocognitive correlates of recovery from schizophrenia. Psychological Medicine 2005;35:1165-73
2. SHARMA T, ANTONOVA L: Cognitive function in schizophrenia Deficits, functional consequences, and future treatment. Psychiatr Clin N Am, 2003;26:25-40
3. HARVEY P: Cognitive Impairment in elderly patients with schizophrenia: age related changes. Int J Geriatr Psychiatry 2001; 16:S78-S85
4. BADCOCK J, DRAGOVIC M, FLAVIE, WATERS F, JABLENSKY A: Dimensions of intelligence in schizophrenia: evidence from patients with preserved, deteriorated and compromised intellect. J Psychiat Research 2005;39:11-19
5. SERGI MJ, RASSOVSKY Y, WIDMARK C et al: Social cognition in schizophrenia: relationships with neurocognition and negative symptoms. Schizophrenia research 2007;90:316-324
6. PENN DL, SANNA LJ, ROBERTS DL: Social cognition in schizophrenia: an overview. Schizophrenia Bulletin 2008;34:408-411
7. GREEN MF, OLIVIER B, CRAWLEY JN, PENN DL, SILVERSTEIN S: Social cognition in schizophrenia: recommendations from the measurement and treatment research to improve cognition in schizophrenia new approaches conference. Schizophrenia Bulletin 2005;31:882-7
8. BRüNE M, ABDEL-HAMID M, LEHMKäMPER C, SONNTAG C: Mental state attribution, neurocognitive functioning, and psychopathology: what predicts poor social competence in schizophrenia best? Schizophrenia Research 2007;92:151-9
9. MARQUES-TEIXEIRA J: Conceito da funcionalidade em doentes com perturbações mentais. Revista Saúde Mental 2008;X:7-8
10. APIQUIAN R, ULLOA RE, HERRERA-ESTRELLA M et al: Validity of the Spanish version of the Personal and Social Performance scale in schizophrenia. Schizophrenia Research 2009; 112(1-3):181-6
11. GREEN MF, KERN RS, BRAFF DL, MINTZ J: Neurocognitive deficits and functional outcome in schizophrenia: are we measuring the «right stuff»? Schizophr Bull. 2000;26(1):119-136
12. WILK: Brief cognitive assessment in schizophrenia: normative data for the repeatable battery for the assessment of neuropsychological status 1. Schizophrenia Research 2004;70:175-186
13. KEEFE: The brief assessment of cognition in schizophrenia: reliability, sensitivity, and comparison with a standard neurocognitive battery. Schizophrenia Research 2004; 68:283-297
14. FRAY PJ, ROBBINS TW, SAHAKIAN BJ: Neuropsychiatric applications of CANTAB. Intl J Geriat Psychiatry 1996;11:329-336
15. MARQUES-TEIXEIRA J: Manual de Avaliação da Disfunção Cognitiva na Esquizofrenia. Lisboa: Vale e Vale, Eds 2005
16. NUECHTERLEIN KH, GREEN MF, KERN RS et al: The MATRICS consensus cognitive battery, part 1: test selection, reliability, and validity. Am J Psychiatry 2008;165:203-213
17. GREENWALD AG, MCGHEE DE, SCHWARTZ JKL: Measuring individual differences in implicit cognition: the implicit association test. JPSP 1998;74:1464-80
18. BREKKE JS, HOE M, LONG J, GREEN MF: How neurocognition and social cognition influence functional change during community-based psychosocial rehabilitation for individuals with schizophrenia. Schizophrenia Bulletin 2007;33:1247-56
19. SERGI MJ, GREEN MF, WIDMARK C et al: Social cognition and neurocognition: effects of risperidone, olanzapine, and haloperidol. Am J Psychiatry 2007;164:1585-92
20. PENN D, ROBERTS DL, MUNT ED, SILVERSTEIN E, JONES N, SHEITMAN B: A pilot study of social cognition and interaction training (SCIT) for schizophrenia. Schizophrenia Research 2005;80:357-9
21. LITTRELL KH, PETTY RG, HILLIGOSS NM, KIRSHNER CD, JOHNSON CG: Improvement in social cognition in patients with schizophrenia associated with treatment with olanzapine. Schizophrenia Research 2004;66:201-2
22. BELL M, TSANG HWH, GREIG TC, BRYSON GJ: Neurocognition, social cognition, perceived social discomfort, and vocational outcomes in schizophrenia. Schizophrenia Bulletin 2009;35:738-747
23. CHOI K-H, KWON J-H: Social cognition enhancement training for schizophrenia: a preliminary randomized controlled trial. Community Mental Health Journal 2006;42:177-187
24. BRYSON G, BELL MD: Initial and final work performance inschizophrenia: cognitive and symptom predictors. J Nerv Ment Dis 2003;191:87-92
25. PENN DL, ROBERTS DL, COMBS D, STERNE A: The devel- opment of the social cognition and interaction training program for schizophrenia spectrum disorders. Psychiatric services 2007; 58:449-451
26. A Edição, texto revisto). Lisboa: Climepsi Editores 2004
27. MCGURK SR, MELTZER HY: The role of cognition in vocational functioning in schizophrenia. Schizophrenia Research 2000;45:175-184
28. DICKINSON D, COURSEY RD: Independence and overlap among neurocognitive correlates of community functioning in schizophrenia. Schizophrenia Research 2002;56:161-170
29. YAMASHITA C, MIZUNO M, NEMOTO T, KASHIMA H: Social cognitive problem-solving in schizophrenia: associations with fluency and verbal memory. Psychiatry Research 2005; 134:123-9
30. MILEV P, HO B-C, ARNDT S, ANDREASEN NC: Predictive values of neurocognition and negative symptoms on functional outcome in schizophrenia: a longitudinal first-episode study with 7-year follow-up. Am J Psychiatry 2005;162:495-506
31. PERLICK DA, ROSENHECK RA, KACZYNSKI R, BINGHAM S, COLLINS J: Association of symptomatology and cognitive deficits to functional capacity in schizophrenia. Schizophrenia Research 2008;99:192-9
32. MOHAMED S, ROSENHECK R, SWARTZ M, STROUP S, LIEBERMAN JA, KEEFE RSE: Relationship of cognition and psychopathology to functional impairment in schizophrenia. Am J Psychiatry 2008;165:978-987
33. MATZA LS, BUCHANAN R, PURDON S, BREWSTER-JORDAN J, ZHAO Y, REVICKI DA: Measuring changes in functional status among patients with schizophrenia: the link with cognitive impairment. Schizophrenia Bulletin 2006;32:666-678
34. ADDINGTON J, ADDINGTON D, GASBARRE L: Neurocognitive and social functioning in schizophrenia and other diagnoses. Schizophrenia Research 2001;48:367-8
35. VELLIGAN DI, BOW-THOMAS CC, MAHURIN RK, MILLER AL, HALGUNSETH LC: Do specific deficits predict specific domains of community function in schizophrenia? J Nerv Ment Dis 2000;188:518-524
36. VAN BEILEN M, KIERS HAL, BOUMA A et al: Cognitive deficits and social functioning in schizophrenia: a clinical perspective. The Clinical Neuropsychologist 2003;17:507-514
37. VELLIGAN DI, PRIHODA TJ, SUI D, RITCH JL, MAPLES N, MILLER AL: The effectiveness of quetiapine versus conventional antipsychotics in improving cognitive and functional outcomes in standard treatment settings. J Clin Psychiatry 2003; 64:524-531
38. PROUTEAU A, VERDOUX H, BRIAND C et al: The crucial role of sustained attention in community functioning in outpatients with schizophrenia. Psychiatry Research 2004;129:171-7
39. REED RA, HARROW M, HERBENER ES, MARTIN EM: Executive function in schizophrenia: is it linked to psychosis and poor life functioning? J Nerv Ment Dis2002;190:725-732
40. BELL MD, TSANG HWH, GREIG T, BRYSON G: Cognitive predictors of symptom change for participants in vocational rehabilitation. Schizophrenia Research 2007;96:162-8
41. EVANS JD, BOND GR, MEYER PS et al: Cognitive and clinical predictors of success in vocational rehabilitation in schizophrenia. Schizophrenia Research 2004;70:331-342
42. KURTZ MM, WEXLER BE, FUJIMOTO M, SHAGAN DS, SELTZER JC: Symptoms versus neurocognition as predictors of change in life skills in schizophrenia after outpatient rehabilitation. Schizophrenia Research 2008;102:303-311
43. TWAMLEY EW, DOSHI RR, NAYAK GV et al: Generalized cognitive impairments, ability to perform everyday tasks, and level of independence in community living situations of older patients with psychosis. Am J Psychiatry 2002;159:2013-20
44. MOROSINI PL, MAGLIANO L, BRAMBILLA L, UGOLINI S, PIOLI R: Development, reliability and acceptability of a new version of the DSM-IV social and occupational functioning assessment scale (SOFAS) to assess routine social functioning. Acta Psychiatr Scand 2000;10:323-9
45. LANCASTER RS, EVANS JD, BOND GR, LYSAKER PH: Social cognition and neurocognitive deficits in schizophrenia. J Nerv Ment Dis 2003;191:295-9
46. GOLDMAN HH, SKODOL AE, LAVE TR: Revising axis V for DSM-IV: a review of measures of social functioning. Am J Psychiatry 1992;149:1148-56
47. HEINRICHS Z: Neurocognitive deficit in schizophrenia: a quantitative review of the evidence. Neuropsychology 1998; 12:426-445
48. RUND: A review of longitudinal studies of cognitive functions in schizophrenia patients. Schizophrenia Bulletin 1998;24:425-435
49. GREEN MF, KERN RS, HEATON RK: Longitudinal studies of cognition and functional outcome in schizophrenia: implications for MATRICS. Schizophrenia Research 2004;72:41-51
50. ROBINSON LJ, THOMPSON JM, GALLAGHER P et al: A meta-analysis of cognitive deficits in euthymic patients with bipolar disorder. J Affective Disorders 2006;93:105-115
51. LEE J, PARK S: Working memory impairments in schizophrenia: a meta-analysis. J Abnormal Psychol 2005;114:599-611
52. FIORAVANTI M, CARLONE O, VITALE B, CINTI M, CLARE L: A meta-analysis of cognitive deficits in adults with a diagnosis of schizophrenia. Neuropsychology Review 2005;15:73-95
53. NIEUWENSTEIN MR, ALEMAN A, DE HAAN EHF: Relationship between symptom dimensions and neurocognitive functioning in schizophrenia: a meta-analysis of WCST and CPT studies. Journal of Psychiatric Research 2001;35:119-125
54. ALLEN DN, GOLDSTEIN G, WARNICK E: A consideration of neuropsychologically normal schizophrenia. Journal of the International Neuropsychological Society 2003;9:56-63
55. PEUSKENS J, DEMILY C, THIBAUT F: Treatment of cognitive dysfunction in schizophrenia. Clinical Therapeutics 2005; 27:S25-S37
56. BRYSON G, GREIG T, LYSAKER P, BELL M: Longitudinal Wisconsin Card Sorting performance in schizophrenia patients in rehabilitation. Applied Neuropsychology 2002;9:203-209
57. KURTZ MM: Neurocognitive impairment across the lifespan in schizophrenia: an update. Schizophrenia Research 2005;74:15-26
58. GREEN MF: What are the functional consequences of neurocognitive deficits in schizophrenia? Am J Psychiatry 1996; 153:321-330
59. SERGI MJ, RASSOVSKY Y, NUECHTERLEIN KH, GREEN MF: Social perception as a mediator of the influence of early visual processing on functional status in schizophrenia. Am J Psychiatry 2006;163:448-454
60. SMITH TE, HULL JW, ROMANELLI S, FERTUCK E, WEISS KA: Symptoms and neurocognition as rate limiters in skills train- ing for psychotic patients. Am J Psychiatry 1999;156:1817-8
61. SMITH TE, HULL JW, GOODMAN M et al: The relative influences of symptoms, insight, and neurocognition on social adjustment in schizophrenia and schizoaffective disorders. J Nerv Ment Dis 1999;187:102-8
62. ADDINGTON J, ADDINGTON D: Neurocognitive and social functioning in schizophrenia: a 2.5 year follow-up study. Schizophrenia Research 2000;44:47-56
63. WILLIAMS LM, WHITFORD TJ, FLYNN G et al: General and social cognition in first episode schizophrenia: identification of separable factors and prediction of functional outcome using the IntegNeuro test battery. Schizophrenia research 2008;99:182-191
64. BRISSOS S, DIAS VV, CARITA AI, MARTINEZ-ARáN A: Quality of life in bipolar type I disorder and schizophrenia in remission: clinical and neurocognitive correlates. Psychiatry Res 2008;160:55-62
65. DICKINSON D, BELLACK AS, GOLD JM: Social/communication skills, cognition, and vocational functioning in schizophrenia. Schizophrenia bulletin 2007;33:1213-1220
66. PINKHAM AE, PENN DL: Neurocognitive and social cognitive predictors of interpersonal skill in schizophrenia. Psychiatry Research 2006;143:167-178
67. HARVEY PD, GREEN MF, KEEFE RSE, VELLIGAN DI: Cognitive functioning in schizophrenia: a consensus statement on its role in the definition and evaluation of effective treatments for the illness. J Clin Psychiatry 2004;65:361-372
68. KASPER S, RESINGER E: Cognitive effects and antipsychotic treatment. Psychoneuroendocrinology 2003;28:27-38
69. CHUA L, CHONG SA, PANG E, NG VPY, CHAN YH: The effect of risperidone on cognitive functioning in a sample of Asian patients with schizophrenia in Singapore. Singapore Med J 2001; 42:243-246
70. HARVEY PD: Ziprasidone and cognition: the evolving story. J Clin Psychiatry 2003;64[Suppl 19]:33-9
71. STRATTA P, DONDOA P, ROSSI A, ROSSI A: Executive function assessment of patients with schizophrenic disorder residual type in olanzapine treatment: an open study. Hum Psychopharmacol Clin Exp 2005;20:401-8
72. KERN RS, GREEN MF, CORNBLATT BA et al: The neurocognitive effects of aripiprazole: an open-label comparison with olanzapine. Psychopharmacology 2006;187:312-320
73. BILDER RM, GOLDMAN RS, VOLAVKA J et al: Neurocognitive effects of clozapine, olanzapine, risperidone, and haloperidol in patients with chronic schizophrenia or schizoaffective disorder. Am J Psychiatry 2002;159:1018-1028
74. REMILLARD S, POURCHER E, COHEN H: The effect of neuroleptic treatments on executive function and symptomatology in schizophrenia: a 1-year follow up study. Schizophrenia Research 2005;80:99-106
75. KEEFE RSE, YOUNG CA, ROCK SL, PURDON SE, GOLD JM, BREIER A: One-year double blind study of the neurocognitive efficacy of olanzapine, risperidone, and haloperidol in schizophrenia. Schizophrenia Research 2006;81:1-15
76. POTKIN SG, FLEMING K, JIN Y, GULASEKARAM B: Clozapine enhances neurocognition and clinical symptomatology more than standard neuroleptics. J Clin Psychopharmacol 2001; 21:479-483
77. KEEFE RSE, BILDER RM, DAVIS SM et al: Neurocognitive effects of antipsychotic medications in patients with chronic schizophrenia in the CATIE trial. Arch Gen Psychiatry 2007; 64:633-647
78. LINDENMAYER J-P, KHAN A, ISKANDER A, ABAD MT, PARKER B: A randomized controlled trial of olanzapine versus haloperidol in the treatment of primary negative symptoms and neurocognitive deficits in schizophrenia. J Clin Psychiatry 2007; 68:368-379
79. KEEFE RSE, SEIDMAN LJ, CHRISTENSEN BK et al: Comparative effect of atypical and conventional antipsychotic drugs on neurocognition in first-episode psychosis: a randomized, double- blind trial of olanzapine versus low doses of haloperidol. Am J Psychiatry 2004;161:985-995
80. KEEFE RSE, SWEENEY JA, GU H et al: Effects of olanzapine, quetiapine, and risperidone on neurocognitive function in early psychosis: a randomized, double-blind 52-week comparison. Am J Psychiatry 2007;164:1061-71
81. MARDER SR: Drug initiatives to improve cognitive function. J Clin Psychiatry 2006;67:S31-S35
82. JANN MW: Implications for atypical antipsychotics in the treatment of schizophrenia: neurocognition effects and a neuroprotective hypothesis. Pharmacotherapy 2004;24:1759-83
83. MENZIES L, OOI C, KAMATH S et al: Effects of a- aminobutyric acid-modulating drugs on working memory and brain function in patients with schizophrenia. Arch Gen Psychiatry 2007; 64:156-167
84. MELTZER HY, BOBO WV, NUAMAH IF et al: Efficacy and tolerability of oral paliperidone extended-release tablets in the treatment of acute schizophrenia pooled data from three 6-week, placebo-controlled studies. J Clin Psychiatry 2008;69:817-829
85. ADDINGTON J, SAEEDI H, ADDINGTON D: Facial affect recognition: a mediator between cognitive and social functioning in psychosis? Schizophrenia Research 2006;85:142-150
86. VAUTH R, RüSCH N, WIRTZ M, CORRIGAN PW: Does social cognition influence the relation between neurocognitive deficits and vocational functioning in schizophrenia? Psychiatry Research 2004;128:155-165
87. MCGURK SR, TWAMLEY EW, SITZER DI, MCHUGO GJ, MUESER KT: A meta-analysis of cognitive remediation in schizophrenia. Am J Psychiatry 2007;164:1791-1802
88. PFAMMATTER M, JUNGHAN UM, BRENNER HD: Efficacy of psychological therapy in schizophrenia: conclusions from meta-analyses. Schizophrenia Bulletin 2006;32:S64-S80
89. RODER V, BRENNER HD, MULLER D et al: Development of specific social skills training programmes for schizophrenia patients: results of a multicentre study. Acta Psychiatr Scand 2002; 105:363-371
90. PATTERSON TL, LEEUWENKAMP OR: Adjunctive psychosocial therapies for the treatment of schizophrenia. Schizophrenia Research 2008;100:108-119
91. WEXLER BE, BELL MD: Cognitive remediation and vocational rehabilitation for schizophrenia. Schizophrenia Bulletin 2005;31:931-941
92. VELLIGAN DI, KERN RS, GOLD JM: Cognitive rehabilitation for schizophrenia and the putative role of motivation and expectancies. Schizophrenia Bulletin 2006;32:474-485
93. BELL M, BRYSON G, GREIG T, CORCORAN C, WEXLER B: Neurocognitive enhancement therapy with work therapy: effects on neuropsychological test performance. Arch Gen Psychiatry 2001;58:763-8
94. PILLING S, BEBBINGTON P, KUIPERS E et al: Psychological treatments in schizophrenia: II meta-analyses of randomized controlled trials of social skills training and cognitive remediation. Psychological Medicine 2002;32:783-791
95. KURTZ MM, MOBERG PJ, GUR RC, GUR RE: Approaches to cognitive remediation of neuropsychological deficits in schizophrenia: a review and meta-analysis. Neuropsychol Rev 2001; 11:197-209
96. SUSLOW T, SCHONAUER K, AROLT V: Attention training in the cognitive rehabilitation of schizophrenic patients: a review of efficacy studies. Acta Psychiatr Scand 2001;103:15-23
97. KRABBENDAM L, ALEMAN A: Cognitive rehabilitation in schizophrenia: a quantitative analysis of controlled studies. Psychopharmacology 2003;169:376-382
98. TWAMLEY EW, JESTE DV, BELLACK AS: A review of cognitive training in schizophrenia. Schizophrenia Bulletin 2003; 29:359-382
99. MCGURK SR, MUESER KT, PASCARIS A: Cognitive training and supported employment for persons with severe mental illness: one-year results from a randomized controlled trial. Schizophrenia Bulletin 2005;31:898-909
100. WYKES T, REEDER C, WILLIAMS C, CORNER J, RICE C, EVERITT B: Are the effects of cognitive remediation therapy (CRT) durable? Results from an exploratory trial in schizophrenia. Schizophrenia Research 2003;61:163-174
101. MEDALIA A, REVHEIM N, CASEY M: Remediation of problem-solving skills in schizophrenia: evidence of a persistent effect. Schizophrenia Research 2002;57:165-171
102. MEDALIA A, RICHARDSON R: What predicts a good response to cognitive remediation interventions? Schizophrenia Bulletin 2005;31:942-953
103. KUPERBERG G, HECKERS S: Schizophrenia and cognitive function. Cur Opin Neurobiol 2000;10:205-210
104. RODER V, MUELLER DR, MUESER KT, BRENNER HD: Integrated psychological therapy (IPT) for schizophrenia: is it effective? Schizophrenia Bulletin 2006;32:S81-S93
105. COMBS DR, ADAMS SD, PENN DL, ROBERTS D, TIEGREEN J, STERN P: Social cognition and interaction training (SCIT) for inpatients with schizophrenia spectrum disorders: preliminary findings. Schizophrenia Research 2007;91:112-6